Toshiba America Medical Systems named Peter N.S. Annand tothe position of senior vice president of sales, marketing, serviceand ultrasound this month. The move provides company-wide seniormanagement support for TAMS president Kunio Sumikawa, which
Toshiba America Medical Systems named Peter N.S. Annand tothe position of senior vice president of sales, marketing, serviceand ultrasound this month. The move provides company-wide seniormanagement support for TAMS president Kunio Sumikawa, which hadbeen lacking for two years.
Annand will be the highest ranking non-Japanese in the multimodalityimaging vendor's U.S. operations, with responsibility for allmodality products. He fills the role at Tustin, CA-based TAMSthat was left vacant by the departure of Ronald B. Schilling in1991 (SCAN 1/29/92).
The executive comes to TAMS from Toshiba's Australiansubsidiary,where he was general manager of the medical division for fouryears. This division's sales grew 44% during his tenure. Annandhas 30 years' experience in the medical industry, having servedin Australia, Canada and the U.S.
In other Toshiba news, the vendor received Food and Drug Administration510(k) clearance last month for its Flexart 0.5-tesla MRI scanner.
Flexart is based on a high-speed RISC microprocessor and hasan icon-based X-Windows graphical user interface for easier operation.Flexart was introduced at last year's Radiological Society ofNorth America meeting (SCAN 11/17/93). The unit is Toshiba's premiummid-field offering.
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?
April 4th 2025Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.